In conclusion, the TAPSE/PASP ratio, as a substitute for RVPAC, is the expression of a key risk factor in HFpEF patients, which is independently associated with the composite endpoint of all‐cause death or HF‐related recurrent hospitalization. Here, CPB1 is linked to hydrops fetalis.